NO175641C - Fremgangsmåte for fremstilling av blandingskrystaller av insulin og insulinderivater - Google Patents

Fremgangsmåte for fremstilling av blandingskrystaller av insulin og insulinderivater

Info

Publication number
NO175641C
NO175641C NO882207A NO882207A NO175641C NO 175641 C NO175641 C NO 175641C NO 882207 A NO882207 A NO 882207A NO 882207 A NO882207 A NO 882207A NO 175641 C NO175641 C NO 175641C
Authority
NO
Norway
Prior art keywords
insulin
des
human
preparation
mixed crystals
Prior art date
Application number
NO882207A
Other languages
English (en)
Other versions
NO882207D0 (no
NO175641B (no
NO882207L (no
Inventor
Michael Dorschug
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO882207D0 publication Critical patent/NO882207D0/no
Publication of NO882207L publication Critical patent/NO882207L/no
Publication of NO175641B publication Critical patent/NO175641B/no
Publication of NO175641C publication Critical patent/NO175641C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
NO882207A 1987-05-22 1988-05-20 Fremgangsmåte for fremstilling av blandingskrystaller av insulin og insulinderivater NO175641C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873717370 DE3717370A1 (de) 1987-05-22 1987-05-22 Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus

Publications (4)

Publication Number Publication Date
NO882207D0 NO882207D0 (no) 1988-05-20
NO882207L NO882207L (no) 1988-11-23
NO175641B NO175641B (no) 1994-08-01
NO175641C true NO175641C (no) 1994-11-09

Family

ID=6328227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882207A NO175641C (no) 1987-05-22 1988-05-20 Fremgangsmåte for fremstilling av blandingskrystaller av insulin og insulinderivater

Country Status (20)

Country Link
US (1) US5028587A (no)
EP (1) EP0291863B1 (no)
JP (1) JPS63303930A (no)
KR (1) KR880013572A (no)
AT (1) ATE71842T1 (no)
AU (1) AU601280B2 (no)
CA (1) CA1335924C (no)
DE (2) DE3717370A1 (no)
DK (1) DK278088A (no)
ES (1) ES2032896T3 (no)
FI (1) FI93797C (no)
GR (1) GR3004344T3 (no)
HU (1) HU203840B (no)
IE (1) IE60649B1 (no)
IL (1) IL86452A (no)
NO (1) NO175641C (no)
NZ (1) NZ224715A (no)
PH (1) PH25587A (no)
PT (1) PT87523B (no)
ZA (1) ZA883599B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
WO1992010284A2 (en) 1990-12-07 1992-06-25 Cnc Development, Inc. Catalytic chemical reactor
WO1992020367A1 (en) * 1991-05-24 1992-11-26 Amylin Pharmaceuticals, Inc. Treatment of anorexia and related states
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
US5597893A (en) * 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
US6004549A (en) * 1994-12-14 1999-12-21 Schering Corporation Crystalline protein controlled release compositions
CO4970787A1 (es) * 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
CN1125081C (zh) 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
CA2431033A1 (en) * 2001-02-09 2002-08-22 Genentech, Inc. Crystallization of igf-1
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity
CA2669815A1 (en) * 2006-11-28 2008-06-05 Marinus Pharmaceuticals Nanoparticulate formulations and methods for the making and use thereof
EP3077414B1 (en) 2013-12-04 2020-06-17 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
WO2016032869A1 (en) 2014-08-26 2016-03-03 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin or insulin analog compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
EG12098A (en) * 1974-04-13 1980-12-31 Hoechst Ag New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
EP0291863B1 (de) 1992-01-22
NO882207D0 (no) 1988-05-20
DE3717370A1 (de) 1988-12-01
US5028587A (en) 1991-07-02
IL86452A (en) 1993-02-21
ATE71842T1 (de) 1992-02-15
EP0291863A2 (de) 1988-11-23
PT87523B (pt) 1992-09-30
NZ224715A (en) 1990-04-26
DK278088D0 (da) 1988-05-20
PT87523A (pt) 1989-05-31
JPS63303930A (ja) 1988-12-12
CA1335924C (en) 1995-06-13
PH25587A (en) 1991-08-08
ES2032896T3 (es) 1993-03-01
KR880013572A (ko) 1988-12-21
ZA883599B (en) 1989-01-25
HU203840B (en) 1991-10-28
NO175641B (no) 1994-08-01
DE3867903D1 (de) 1992-03-05
HUT46546A (en) 1988-11-28
FI93797B (fi) 1995-02-28
IE60649B1 (en) 1994-08-10
FI93797C (fi) 1995-06-12
GR3004344T3 (no) 1993-03-31
FI882354A (fi) 1988-11-23
IE881522L (en) 1988-11-22
AU601280B2 (en) 1990-09-06
AU1648788A (en) 1988-11-24
NO882207L (no) 1988-11-23
FI882354A0 (fi) 1988-05-19
IL86452A0 (en) 1988-11-15
DK278088A (da) 1988-11-23
EP0291863A3 (en) 1990-04-04

Similar Documents

Publication Publication Date Title
NO175641C (no) Fremgangsmåte for fremstilling av blandingskrystaller av insulin og insulinderivater
DK642587D0 (da) Insulinpraeparat
ZA845620B (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
YU101385A (en) Process for obtaining crystal calcium pseudomonate or its hydrate
KR880701738A (ko) Co₂처리에 의한 알기네이트 또는 타 우론산의 변형
FI885488A (fi) 2,2-difluorisyklopropyylietaanijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö tuholaisten torjunta-aineina
NO871599L (no) Sammensetning for stimulering av kondrocytter og osteoblaster (osseinhydroksyapatittforbindelse), fremgangsmaate for fremstilling derav og farmasoeytiske preparater inneholdende sammensetningen.
DE3560949D1 (en) New somatostatin compounds, process for their synthesis, preparation for veterinary use containing said compound and process for the treatment of animals
DE3885818D1 (de) Trinatriumsalz des 2,4,6-Trimercapto-s-triazin-nonahydrats und Verfahren zur Herstellung.
JPS645460A (en) Production of delaying gelatinous material
DE69014747D1 (de) Verfahren zur Herstellung von Kaliumtitanarsenat-Einkristallen.
SE8703512D0 (sv) Medel for tandbehandling
UA8036A1 (uk) Спосіб одержання похідних тіазолу або їх кислотно-аддітивних солей
NZ236206A (en) Preparation of 2'-methyl-4'-methylenespiro(androstadiene-17,5'(4'h)-oxazol)-3-one derivatives from pregn-5-en-20-ylideneacetamide derivatives by treatment with vilsmeier reagent or acid
ES2049068T3 (es) Procedimiento de preparacion de una carne aromatizada desecada.
ATE88064T1 (de) Verfahren zur bereitung von aromatisiertem fleisch.
SU1840597A1 (ru) Способ получения бис-(хлороксимино)-ацетона